Researchers from the Center for Health Incentives and Behavioral Economics (CHIRP) found that women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), have a significantly higher risk of cardiovascular disease.
Published in The Lancet Obstetrics, Gynaecology & Women’s Health, the study found that women with PMOS were more than four times as likely to develop atherosclerotic cardiovascular disease, including heart attack and stroke, compared with women without PMOS. This elevated risk remained even after accounting for other cardiovascular risk factors.
The findings highlight the importance of cardiovascular risk assessment and prevention among women with PMOS. The study has also received recent media coverage from Healthline and Penn Medicine News.